JAN 27, 2017 01:49 PM PST

A.I. on Par With Doctors in Diagnosing Melanoma

WRITTEN BY: Xuan Pham

Can a smartphone be smart enough to warn users if their mole is actually deadly skin cancer? Not quite yet, but scientists from Stanford are marching in that direction. Recently, they made a huge step by developing and training an artificial intelligence (AI) software to diagnose melanoma. The AI, researchers say, has nearly the same accuracy as trained doctors.

Motivated by the desire for universal access to health care, doctors repurposed an AI software from Google that could differentiate between pictures of cats versus dogs. Using this software, the team trained the AI on database of nearly 130,000 images of skin conditions, curated to represent over 2,000 different diseases. This allowed the machine to learn the hallmarks of skin abnormalities. And instead of cats versus dogs, the machine can differentiate between benign moles and malignant melanomas.

“We realized it was feasible, not just to do something well, but as well as a human dermatologist,” said Sebastian Thrun, an adjunct professor in the Stanford Artificial Intelligence Laboratory, and the study’s senior author. “That’s when our thinking changed. That’s when we said, ‘Look, this is not just a class project for students, this is an opportunity to do something great for humanity.’”

Stanford scientists then pitted their AI against 21 trained dermatologists. They found that the AI performed as good as the human doctors. The AI achieved “performance on par with all tested experts…, demonstrating an artificial intelligence capable of classifying skin cancer with a level of competence comparable to dermatologists,” the authors wrote in their paper, published in Nature

While doctors and pathologists are still quite vital to confirming the diagnosis, the Stanford team are excited about the prospects of integrating the AI for public use. In particular, they hope to incorporate the technology into smartphones, taking full advantage of the widespread use of these mobile devices.

"The application of AI to healthcare is, we believe, an incredibly exciting area of research that can be leveraged to achieve a great deal of societal good," said Andre Esteva, the study’s lead author. "One particular route that we find exciting is the use of this algorithm on a mobile device, but to achieve this we would have to build an app and test its accuracy directly from a mobile device."

On an even grander scale, Esteva hopes medical AI may soon apply to other diseases other than melanoma. “Everyone will have a supercomputer in their pockets with a number of sensors in it, including a camera. What if we could use it to visually screen for skin cancer? Or other ailments?”

Before that happens, however, the Stanford team’s melanoma AI detector must be rigorously tested in clinics. And even then, it may be unlikely that AI will completely replace human doctors. And this may just be for the better. 

Additional sources: Stanford University,  BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Identifying New Drug Targets in Therapy-Resistant Cancers
Recent research published in the Nature Partner journal Systems Biology and Applications examines how genome-wide data used in collaboration with systems b...
JUL 17, 2018
Cancer
JUL 17, 2018
Large Multifactorial NIH Study Announced for Prostate Cancer Aggressiveness in African-American Men
The largest coordinated study on Prostate cancer aims to look at both genetic and environmental factors that lead to increased risk and cancer aggressiveness in African-American men compared...
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
OCT 02, 2018
Health & Medicine
OCT 02, 2018
Many Patients Are Unaware of Increased Cancer Risk
Just as recently as a few decades ago, many common health screenings were not readily available. Mammography, for breast cancer detection, wasn't ...
Loading Comments...